
Being overweight or obese may be associated with poor response to zzso The present report explores the moderation of zzso response by body weight to establish the specificity to zzso mode of action, type of depressive symptoms and zzso 

Height and weight were measured in zzso men and women with major depression treated with zzso or zzso for twelve weeks as part of the Genome Based zzso Drugs for Depression zzso zzso Body mass index zzso and obesity zzso were tested as zzso of change in depressive symptoms using mixed linear zzso 

Higher zzso and obesity predicted poor response to zzso but did not significantly influence response to zzso The moderation of response by body weight was due to differential improvement in zzso symptoms, including sleep and zzso The relationship between body weight and change in zzso symptoms was moderated by gender with obese men responding less to zzso and obese women having poorer response to both zzso 

As no zzso arm was included, the specificity of findings to zzso is zzso Lack of specific measures precluded accounting for differences in body fat zzso 

Body weight should be considered in the assessment of depression as it may inform the selection of zzso zzso 

